1. Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era 
Veli K. Topkara, MD, Sreekanth Kondareddy, MD, Fardina Malik, MD, I.-Wen Wang, MD, PhD, Douglas L. Mann, MD, Gregory A. Ewald, MD, Nader Moazami, MD 
The Annals of Thoracic Surgery 
Volume 90, Issue 4, Pages (October 2010)
DOI: /j.athoracsur
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Survival of patients on left ventricular assist device support based on presence of infection (black line) or absence of infection (gray line) of any type. Censored observations indicates patients who are transplanted or ongoing at the time of study.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Survival of patients on left ventricular assist device support based on presence of sepsis (black line) or absence of sepsis (gray line). Censored observations indicates patients who are transplanted or ongoing at the time of study.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Effect of nonsystemic infections on survival of patients on left ventricular assist device (LVAD) support: (A) LVAD-related infections (black line) or no LVAD infection (gray line). (B) Local non–LVAD-related infections (black line) or no local infection (gray line).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions